The human Y-encoded testis-specific protein interacts functionally with eukaryotic translation elongation factor eEF1A, a putative oncoprotein

International Journal of Cancer

Volumn 123, Issue 7, 2008, Pages 1573-1585

  Kido, Tatsuo ^a   Lau, Yun Fai Chris ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

eEF1A; Protein synthesis; Protein protein interaction; Seminoma; TSPY

Indexed keywords

EUKARYOTIC TRANSLATION ELONGATION FACTOR EEF1A; EUKARYOTIC TRANSLATION ELONGATION FACTOR EEF1A2; ONCOPROTEIN; TESTIS SPECIFIC PROTEIN Y ENCODED; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; EEF1A1 PROTEIN, HUMAN; ELONGATION FACTOR 1; PRIMER DNA; TSPY1 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; BREAST CANCER; CARCINOGENESIS; CELL NUCLEUS; CELL STRAIN COS7; CONTROLLED STUDY; CYTOPLASM; DNA LIBRARY; GENE EXPRESSION; GENE LOCUS; GENETIC CONSERVATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GERM CELL TUMOR; GONADOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; MALE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; REPORTER GENE; SEMINOMA; TWO HYBRID SYSTEM; Y CHROMOSOME; YEAST; ANIMAL; CELL LINE; CELL STRAIN COS1; CERCOPITHECUS; DIMERIZATION; GENETICS; METABOLISM; NEOPLASM; NUCLEOTIDE SEQUENCE; PROTEIN BINDING; SPERMATOZOON; TESTIS;

ANIMALS; BASE SEQUENCE; CELL CYCLE PROTEINS; CELL LINE; CERCOPITHECUS AETHIOPS; CHROMOSOMES, HUMAN, Y; COS CELLS; DIMERIZATION; DNA PRIMERS; HUMANS; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; PEPTIDE ELONGATION FACTOR 1; PROTEIN BINDING; SPERMATOZOA; TESTIS; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 50549103311     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23697     Document Type: Article

References (61)

1. Zhang JS, Yang-Feng TL, Muller U, Mohandas TK, de Jong PJ, Lau YF. Molecular isolation and characterization of an expressed gene from the human Y chromosome. Hum Mol Genet 1992;1:717-26.
2. Arnemann J, Epplen JT, Cooke HJ, Sauermann U, Engel W, Schmidtke J. A human Y-chromosomal DNA sequence expressed in testicular tissue. Nucleic Acids Res 1987;15:8713-24.
3. Kido T, Lau YF. A Cre gene directed by a human TSPY promoter is specific for germ cells and neurons. Genesis 2005;42:263-75.
4. Honecker F, Stoop H, de Krijger RR, Chris Lau YF, Bokemeyer C, Looijenga LH. Pathobiological implications of the expression of markers of testicular carcinoma in situ by fetal germ cells. J Pathol 2004;203:849-57.
5. Schnieders F, Dork T, Arnemann J, Vogel T, Werner M, Schmidtke J. Testis-specific protein. Y-encoded (TSPY) expression in testicular tissues. Hum Mol Genet 1996;5:1801-7.
6. Salo P, Kaariainen H, Petrovic V, Peltomaki P, Page DC, de la Chapelle A. Molecular mapping of the putative gonadoblastoma locus on the Y chromosome. Genes Chromosomes Cancer 1995;14:210-14.
7. Tsuchiya K, Reijo R, Page DC, Disteche CM. Gonadoblastoma: molecular definition of the susceptibility region on the Y chromosome. Am J Hum Genet 1995;57:1400-7.
8. Page DC. Hypothesis: a Y-chromosomal gene causes gonadoblastoma in dysgenetic gonads. Development 1987;101 (Suppl.):151-5.
9. Kersemaekers AM, Honecker F, Stoop H, Cools M, Molier M, Wolffenbuttel K, Bokemeyer C, Li Y, Lau YF, Oosterhuis JW, Looijenga LH. Identification of germ cells at risk for neoplastic transformation in gonadoblastoma: an immunohistochemical study for OCT3/4 and TSPY. Hum Pathol 2005;36:512-21.
10. Li Y, Vilain E, Conte F, Rajpert-De Meyts E, Lau YF. Testis-specific protein Y-encoded gene is expressed in early and late stages of gonadoblastoma and testicular carcinoma in situ. Urol Oncol 2007;25:141-6.
11. Li Y, Tabatabai ZL, Lee TL, Hatakeyama S, Ohyama C, Chan WY, Looijenga LH, Lau YF. The Y-encoded TSPY protein: a significant marker potentially plays a role in the pathogenesis of testicular germ cell tumors. Hum Pathol 2007;38:1470-81.
12. Lau Y, Chou P, Iezzoni J, Alonzo J, Komuves L. Expression of a candidate gene for the gonadoblastoma locus in gonadoblastoma and testicular seminoma. Cytogenet Cell Genet 2000;91:160-4.
13. Lau YF, Zhang J. Expression analysis of thirty one Y chromosome genes in human prostate cancer. Mol Carcinog 2000;27:308-21.
14. Lau YF, Lau HW, Komuves LG. Expression pattern of a gonadoblastoma candidate gene suggests a role of the Y chromosome in prostate cancer. Cytogenet Genome Res. 2003;101:250-60.
15. Yin YH, Li YY, Qiao H, Wang HC, Yang XA, Zhang HG, Pang XW, Zhang Y, Chen WF. TSPY is a cancer testis antigen expressed in human hepatocellular carcinoma. Br J Cancer 2005;93:458-63.
16. Gallagher WM, Bergin OE, Rafferty M, Kelly ZD, Nolan IM, Fox EJ, Culhane AC, McArdle L, Fraga MF, Hughes L, Currid CA, O'Mahony F, et al. Multiple markers for melanoma progression regulated by DNA methylation: insights from transcriptomic studies. Carcinogenesis 2005;26:1856-67.
17. Oram SW, Liu XX, Lee TL, Chan WY, Lau YF. TSPY potentiates cell proliferation and tumorigenesis by promoting cell cycle progression in HeLa and NIH3T3 cells. BMC Cancer 2006;6:154.
18. Park YJ, Luger K. Structure and function of nucleosome assembly proteins. Biochem Cell Biol 2006;84:549-58.
19. Ozbun LL, You L, Kiang S, Angdisen J, Martinez A, Jakowlew SB. Identification of differentially expressed nucleolar TGF-β1 target (DENTT) in human lung cancer cells that is a new member of the TSPY/SET/NAP-1 superfamily. Genomics 2001;73:179-93.
20. von Lindern M, van Baal S, Wiegant J, Raap A, Hagemeijer A, Grosveld G. Can, a putative oncogene associated with myeloid leukemogenesis, may be activated by fusion of its 3′ half to different genes: characterization of the set gene. Mol Cell Biol 1992;12:3346-55.
21. Ishimi Y, Kojima M, Yamada M, Hanaoka F. Binding mode of nucleosome-assembly protein (AP-1) and histones. Eur J Biochem 1987;162:19-24.
22. Canela N, Rodriguez-Vilarrupla A, Estanyol JM, Diaz C, Pujol MJ, Agell N, Bachs O. The SET protein regulates G2/M transition by modulating cyclin B-cyclin-dependent kinase 1 activity. J Biol Chem 2003;278:1158-64.
23. Seo SB, McNamara P, Heo S, Turner A, Lane WS, Chakravarti D. Regulation of histone acetylation and transcription by INHAT, a human cellular complex containing the set oncoprotein. Cell 2001;104:119-30.
24. Karetsou Z, Martic G, Sflomos G, Papamarcaki T. The histone chaperone SET/TAF-Iβ interacts functionally with the CREB-binding protein. Biochem Biophys Res Commun 2005;335:322-7.
25. Compagnone NA, Zhang P, Vigne JL, Mellon SH. Novel role for the nuclear phosphoprotein SET in transcriptional activation of P450c17 and initiation of neurosteroidogenesis. Mol Endocrinol 2000;14:875-88.
26. Wang GS, Hong CJ, Yen TY, Huang HY, Ou Y, Huang TN, Jung WG, Kuo TY, Sheng M, Wang TF, Hsueh YP. Transcriptional modification by a CASK-interacting nucleosome assembly protein. Neuron 2004;42:113-28.
27. Thornton S, Anand N, Purcell D, Lee J. Not just for housekeeping: protein initiation and elongation factors in cell growth and tumorigenesis. J Mol Med 2003;81:536-48.
28. Amiri A, Noei F, Jeganathan S, Kulkarni G, Pinke DE, Lee JM. eEF1A2 activates Akt and stimulates Akt-dependent actin remodeling, invasion and migration. Oncogene 2007;26:3027-40.
29. Shamovsky I, Ivannikov M, Kandel ES, Gershon D, Nudler E. RNA-mediated response to heat shock in mammalian cells. Nature 2006;440:556-60.
30. Kahns S, Lund A, Kristensen P, Knudsen CR, Clark BF, Cavallius J, Merrick WC. The elongation factor 1 A-2 isoform from rabbit: cloning of the cDNA and characterization of the protein. Nucleic Acids Res 1998;26:1884-90.
31. Kulkarni G, Turbin DA, Amiri A, Jeganathan S, Andrade-Navarro MA, Wu TD, Huntsman DG, Lee JM. Expression of protein elongation factor eEF1A2 predicts favorable outcome in breast cancer. Breast Cancer ResTreat 2007;102:31-41.
32. Li R, Wang H, Bekele BN, Yin Z, Caraway NP, Katz RL, Stass SA, Jiang F. Identification of putative oncogenes in lung adenocarcinoma by a comprehensive functional genomic approach. Oncogene 2006;25:2628-35.
33. Tomlinson VA, Newbery HJ, Wray NR, Jackson J, Larionov A, Miller WR, Dixon JM, Abbott CM. Translation elongation factor eEF1A2 is a potential oncoprotein that is overexpressed in two-thirds of breast tumours. BMC Cancer 2005;5:113.
34. Chen L, Madura K. Increased proteasome activity, ubiquitin-conjugating enzymes, and eEF1A translation factor detected in breast cancer tissue. Cancer Res 2005;65:5599-606.
35. Anand N, Murthy S, Amann G, Wernick M, Porter LA, Cukier IH, Collins C, Gray JW, Diebold J, Demetrick DJ, Lee JM. Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer. Nat Genet 2002;31:301-5.
36. Tatsuka M, Mitsui H, Wada M, Nagata A, Nojima H, Okayama H. Elongation factor-1α gene determines susceptibility to transformation. Nature 1992;359:333-6.
37. Oh HJ, Li Y, Lau YF. Sry associates with the heterochromatin protein 1 complex by interacting with a KRAB domain protein. Biol Reprod 2005;72:407-15.
38. Turner DL, Weintraub H. Expression of achaete-scute homolog 3 in Xenopus embryos converts ectodermal cells to a neural fate. Genes Dev 1994;8:1434-47.
39. Rupp RA, Snider L, Weintraub H. Xenopus embryos regulate the nuclear localization of XMyoD. Genes Dev 1994;8:1311-23.
40. Kido T, Lau YF. The rat Tspy is preferentially expressed in elongated spermatids and interacts with the core histones. Biochem Biophys Res Commun 2006;350:56-67.
41. Grassi G, Scaggiante B, Farra R, Dapas B, Agostini F, Baiz D, Rosso N, Tiribelli C. The expression levels of the translational factors eEF1A 1/2 correlate with cell growth but not apoptosis in hepatocellular carcinoma cell lines with different differentiation grade. Biochimie 2007;89:1544-52.
42. Rasband WS. ImageJ, U. S. National Institutes of Health, Bethesda, MD, USA. Available at: http://rsb.info.nih.gov/ij/ 1997-2007.
43. Pan J, Ruest LB, Xu S, Wang E. Immuno-characterization of the switch of peptide elongation factors eEF1A-1/EF-1α and eEF1A-2/S1 in the central nervous system during mouse development. Brain Res Dev Brain Res 2004;149:1-8.
44. Calado A, Treichel N, Muller EC, Otto A, Kutay U. Exportin-5-mediated nuclear export of eukaryotic elongation factor 1A and tRNA. Embo J 2002;21:6216-24.
45. Grosshans H, Simos G, Hurt E. Review: transport of tRNA out of the nucleus-direct channeling to the ribosome? J Struct Biol 2000;129:288-94.
46. Andersen GR, Pedersen L, Valente L, Chatterjee I, Kinzy TG, Kjeldgaard M, Nyborg J. Structural basis for nucleotide exchange and competition with tRNA in the yeast elongation factor complex eEF1A:eEF1Bα. Mol Cell 2000;6:1261-6.
47. Vera J, Estanyol JM, Canela N, Llorens F, Agell N, Itarte E, Bachs O, Jaumot M. Proteomic analysis of SET-binding proteins. Proteomics 2007;7:578-87.
48. Muto S, Senda M, Akai Y, Sato L, Suzuki T, Nagai R, Senda T, Horikoshi M. Relationship between the structure of SET/TAF-Iβ/INHAT and its histone chaperone activity. Proc Natl Acad Sci USA 2007;104:4285-90.
49. Kelley LA, MacCallum RM, Sternberg MJ. Enhanced genome annotation using structural profiles in the program 3D-PSSM. J Mol Biol 2000;299:499-520.
50. Gangwani L, Mikrut M, Galcheva-Gargova Z, Davis RJ. Interaction of ZPR1 with translation elongation factor-1α in proliferating cells. J Cell Biol 1998;143:1471-84.
51. Gangwani L. Deficiency of the zinc finger protein ZPR1 causes defects in transcription and cell cycle progression. J Biol Chem 2006;281:40330-40.
52. Mishra AK, Gangwani L, Davis RJ, Lambright DG. Structural insights into the interaction of the evolutionarily conserved ZPR1 domain tandem with eukaryotic EF1A, receptors, and SMN complexes. Proc Natl Acad Sci USA 2007;104:13930-5.
53. Wagner S, Weber S, Kleinschmidt MA, Nagata K, Bauer UM. SET-mediated promoter hypoacetylation is a prerequisite for coactivation of the estrogen-responsive pS2 gene by PRMT1. J Biol Chem 2006;281:27242-50.
54. Loven MA, Muster N, Yates JR, Nardulli AM. A novel estrogen receptor α-associated protein, template-activating factor Iβ, inhibits acetylation and transactivation. Mol Endocrinol 2003;17:67-78.
55. Shultz LD, Sweet HO, Davisson MT, Coman DR. 'Wasted', a new mutant of the mouse with abnormalities characteristic to ataxia telangiectasia. Nature 1982;297:402-4.
56. Chang YW, Traugh JA. Phosphorylation of elongation factor 1 and ribosomal protein S6 by multipotential S6 kinase and insulin stimulation of translational elongation. J Biol Chem 1997;272:28252-7.
57. Johnston GC, Pringle JR, Hartwell LH. Coordination of growth with cell division in the yeast Saccharomyces cerevisiae. Exp Cell Res 1977;105:79-98.
58. Sonenberg N. Translation factors as effectors of cell growth and tumorigenesis. Curr Opin Cell Biol 1993;5:955-60.
59. Chuang SM, Chen L, Lambertson D, Anand M, Kinzy TG, Madura K. Proteasome-mediated degradation of cotranslationally damaged proteins involves translation elongation factor 1A. Mol Cell Biol 2005;25:403-13.
60. Chang R, Wang E. Mouse translation elongation factor eEF1A-2 interacts with Prdx-1 to protect cells against apoptotic death induced by oxidative stress. J Cell Biochem 2007;100:267-78.
61. Xiao K, McClatchy DB, Shukla AK, Zhao Y, Chen M, Shenoy SK, Yates JR, III, Lefkowitz RJ. Functional specialization of β-arrestin interactions revealed by proteomic analysis. Proc Natl Acad Sci USA 2007;104:12011-16.